NextPharma’s analytical and microbiological laboratories are available to you as a standalone contract testing service, or as an integrated part of a development or commercial manufacturing programme.
The scope of analytical services covers method development, validation and transfer, physico-chemical analytics, non-sterile and sterile microbiology, stability testing, and CoA creation. Many clients use our laboratories for contract analytics alone — method transfer, ICH stability storage, and release testing. Where testing sits alongside a Pharmaceutical Development or Commercial Manufacturing and Packaging programme, testing, stability and release stay aligned to your batch timelines and regulatory milestones.
If you are a sponsor, development or quality lead running a programme that needs analytical support tied directly to it, this page maps our laboratory network, the tests we run for sterile and non-sterile products, our stability capacity, and how release works. All testing is performed to EMA, FDA, ANVISA and ICH requirements and to the relevant pharmacopoeia (EP, USP, BP, JP).
Our Laboratory Network and Centres of Excellence
Every analytical-capable NextPharma site runs the analytical activity for its own dosage forms or analytical services are supported by other NextPharma centres of excellence. Across the network, three centres of excellence anchor specialist testing, so each product type is handled where the relevant expertise and equipment already exist.
| Centre of Excellence | Scope |
| Bielefeld (Germany) | Analytical services and physico-chemical analytics: method development, validation, transfer, routine testing, investigations and stability testing |
| Göttingen (Germany) | Non-sterile microbiology: validation, transfer and routine analysis for microbial limit testing, hygiene monitoring, and preservative efficacy testing |
| Tampere (Finland) | Sterile microbiology: sterility, endotoxin and bioburden testing, drawing on established sterile product development and production experience |
